Back
ESC2025 Premium Access

Selecting patients for targeted therapy with early rhythm control using BMP10 blood biomarker levels

Session: Role of biomarkers in atrial fibrillation
Topic: Rhythm Control, Antiarrhythmic Drugs
Speaker: Mr C. Al-Taie (Hamburg, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Christoph Al-Taie

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
0 follower

7 more presentations in this session

Blood biomarkers and development of Atrial Fibrillation within 1 year, in frail older patients. Outcomes of the Dutch-GERAF study.

Speaker: Mrs J. Spruit (Alkmaar, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Assessment of 352 plasma biomarkers for predicting ischaemic stroke risk in atrial fibrillation patients without anticoagulation - A proteomic profiling study

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Identification of a lactylation-related gene signature as the novel biomarkers for early diagnosis of atrial fibrillation

Speaker: Doctor X. Long (Changsha, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

NT-proBNP may be used as a risk factor of stroke after the elimination of atrial fibrillation by catheter ablation

Speaker: Doctor S. Kudo (Amagasaki, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Inflammatory biomarkers in symptomatic atrial fibrillation: a case-control study

Speaker: Doctor A. Jackson (Orebro, SE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Role of biomarkers in atrial fibrillation

Speakers: Mr C. Al-Taie, Mrs J. Spruit, Associate Professor Z. Hijazi, Doctor X. Long, Doctor S. Kudo...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources